Library / Laws / 116th Congress / House Bills / H.R. 2374
H.R. 2374
To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the efficient review of petitions filed in good faith to raise legitimate public heath concerns, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2019-04-29 | 5.9K | ⠃⠗⠋ |
| Reported in House | 2020-12-24 | 6.3K | ⠃⠗⠋ |